Quest Diagnostics has finalized its acquisition of LifeLabs from OMERS. The transaction was valued at approximately CAD 1.35 billion (~USD 1 billion), including net debt. Quest expects the transaction to generate approximately CAD 970 million (~USD 710 million) in annual revenues.
Post-acquisition, Quest Diagnostics plans to leverage the expertise of both organizations to enhance access to diagnostic services for North American patients and improve patient care for Canada's growing and aging population. The company also plans to enhance online appointment scheduling and quicken patient service center processing activities.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.